Atlas Trials

Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer

Clinical trial NCT05170919 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT05170919
Sponsor
Englewood Hospital and Medical Center
Status
ENROLLING_BY_INVITATION
Phase
Phase 2
Study type
INTERVENTIONAL
Anorexia Nervosa with Significantly Low Body Weight
Start date
2022-01-20
Primary completion
2026-12-01
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.